BreastDefend enhances effect of tamoxifen in estrogen receptor-positive human breast cancer in vitro and in vivo
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1472-6882
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
BreastDefend enhances effect of tamoxifen in estrogen receptor-positive human breast cancer in vitro and in vivo ; volume:17 ; number:1 ; day:16 ; month:2 ; year:2017 ; pages:1-11 ; date:12.2017
BMC complementary and alternative medicine ; 17, Heft 1 (16.2.2017), 1-11, 12.2017
- Keyword
-
Krebs
Onkologie
- Creator
-
Cheng, Shujie
- Contributor
-
Castillo, Victor
Welty, Matt
Alvarado, Mark
Eliaz, Isaac
Temm, Constance J.
Sandusky, George E.
Sliva, Daniel
SpringerLink (Online service)
- DOI
-
10.1186/s12906-017-1621-7
- URN
-
urn:nbn:de:1111-2017031012013
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:56 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Cheng, Shujie
- Castillo, Victor
- Welty, Matt
- Alvarado, Mark
- Eliaz, Isaac
- Temm, Constance J.
- Sandusky, George E.
- Sliva, Daniel
- SpringerLink (Online service)
Other Objects (12)
Raptor localization predicts prognosis and tamoxifen response in estrogen receptor-positive breast cancer
Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen
Nogo-B receptor increases the resistance to tamoxifen in estrogen receptor-positive breast cancer cells
Targeting c-Jun inhibits fatty acid oxidation to overcome tamoxifen resistance in estrogen receptor-positive breast cancer
Small molecule inhibitor targeting the Hsp70-Bim protein–protein interaction in estrogen receptor-positive breast cancer overcomes tamoxifen resistance
Genomic alterations identified by array comparative genomic hybridization as prognostic markers in tamoxifen-treated estrogen receptor-positive breast cancer
The impact of CBP expression in estrogen receptor-positive breast cancer
Local estrogen axis in the human bone microenvironment regulates estrogen receptor-positive breast cancer cells
microRNA Regulation in Estrogen Receptor-Positive Breast Cancer and Endocrine Therapy
Role of BRD4 and histone acetylation in estrogen receptor-positive breast cancers
Overexpressing S100A9 ameliorates NK cell dysfunction in estrogen receptor-positive breast cancer
GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers
Raptor localization predicts prognosis and tamoxifen response in estrogen receptor-positive breast cancer
Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen
Nogo-B receptor increases the resistance to tamoxifen in estrogen receptor-positive breast cancer cells
Targeting c-Jun inhibits fatty acid oxidation to overcome tamoxifen resistance in estrogen receptor-positive breast cancer
Small molecule inhibitor targeting the Hsp70-Bim protein–protein interaction in estrogen receptor-positive breast cancer overcomes tamoxifen resistance
Genomic alterations identified by array comparative genomic hybridization as prognostic markers in tamoxifen-treated estrogen receptor-positive breast cancer
The impact of CBP expression in estrogen receptor-positive breast cancer
Local estrogen axis in the human bone microenvironment regulates estrogen receptor-positive breast cancer cells
microRNA Regulation in Estrogen Receptor-Positive Breast Cancer and Endocrine Therapy
Role of BRD4 and histone acetylation in estrogen receptor-positive breast cancers
Overexpressing S100A9 ameliorates NK cell dysfunction in estrogen receptor-positive breast cancer
GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers
Raptor localization predicts prognosis and tamoxifen response in estrogen receptor-positive breast cancer
Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen
Nogo-B receptor increases the resistance to tamoxifen in estrogen receptor-positive breast cancer cells
Targeting c-Jun inhibits fatty acid oxidation to overcome tamoxifen resistance in estrogen receptor-positive breast cancer
Small molecule inhibitor targeting the Hsp70-Bim protein–protein interaction in estrogen receptor-positive breast cancer overcomes tamoxifen resistance
Genomic alterations identified by array comparative genomic hybridization as prognostic markers in tamoxifen-treated estrogen receptor-positive breast cancer
The impact of CBP expression in estrogen receptor-positive breast cancer
Local estrogen axis in the human bone microenvironment regulates estrogen receptor-positive breast cancer cells
microRNA Regulation in Estrogen Receptor-Positive Breast Cancer and Endocrine Therapy
Role of BRD4 and histone acetylation in estrogen receptor-positive breast cancers
Overexpressing S100A9 ameliorates NK cell dysfunction in estrogen receptor-positive breast cancer